Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Ophthalmology Webinars & Conferences

Asia Pacific & Middle East
Canada

EYE SURGERY MEET 2024

Welcome Message

Join us for the "5th International Conference on Euro Ophthalmology and Eye Surgery," which is set to take place in the city of lights Paris,France on August 28-29, 2024. This conference is an opportunity for ophthalmologists, eye surgeons, researchers, scholars, and practitioners from across the globe to convene and discuss the latest advancements and innovations in ophthalmology and eye surgery.

About Conference


Join us for the “5th International Conference on Euro Ophthalmology and Eye Surgery, scheduled to be held in Paris, France, on August 28-29, 2024. This event will revolve around the theme "Artificial Intelligence and Digital Health in Ophthalmology," spotlighting the latest advancements and ongoing research in the field. Eye Surgery Meet 2024 will delve into various aspects of, eye anatomy, physiology, diseases, and related topics, with a particular emphasis on innovative surgical techniques for cataract treatment. Attendees can anticipate engaging presentations by scientists and researchers, showcasing cutting-edge research and fostering collaboration. These conferences serve as vibrant platforms for the exchange of knowledge, networking opportunities, and the promotion of collaborative efforts aimed at advancing eye surgery and ophthalmic practices.

Target Audience:

  • Ophthalmologists
  • Ophthalmic Surgeons
  • Optometrists
  • Opticians
  • Vision Scientists
  • Researchers and Scientists
  • Professors and Academics
  • Residents and Fellows in Ophthalmology
  • Eye Care Practitioners
  • Medical Students
  • Ophthalmic Nurses
  • Pharmaceutical Companies
  • Medical Devices Companies
  • Ophthalmic Associations and Societies
  • Healthcare Professionals
  • Ophthalmology Technicians
  • Rehabilitation Specialists
  • Entrepreneurs in Ophthalmology
  • Ocularists
  • Ophthalmology and Eye Surgery

Why to Attend:                    

Eye Surgery Meet 2024 initially aids in extending the network around us and mainly connects us with like-minded people as well as peers in the industry. This conference enables you to communicate your thoughts and your work to others, as well as to learn outside of the field or area of interest. It not only aids in the development of knowledge about your subject but also helps in the detection of problems in your research.

Market Analysis

The global ophthalmic drugs market size was valued at USD 33.81 billion in 2022 and is expected to witness a compound annual growth rate (CAGR) of 7.80% from 2023 to 2030. Increasing research and development activities to develop and launch novel ophthalmic drugs, and various strategic initiatives anticipated by the key players are anticipated to boost the demand. According to the October 2021 report of World Health Organization on blindness and vision impairment, it is estimated that almost 2.2 billion people have distance or near vision impairment disorders and among them half of these cases i.e. at least 1 billion cases can be prevented with the help of appropriate treatment. This high prevalence is adding up the financial burden on the governments. For instance, vision impairment from myopia alone is estimated to be USD 244 billion.

The COVID-19 pandemic had an adverse impact on the ophthalmic drugs market. For instance, according to Clinical Ophthalmology Journal, in November 2021. In the analysis of post-pandemic and pre-pandemic data, it can be predicted that visual field checkups, clinical visits, medications released, and surgical procedures declined 93.84% ,92.52%,19.63%, and 72.74% at the time when pre and post-pandemic times were compared.

Route of Administration Insights:

The topical route of administration has dominated the ophthalmic drugs market in 2022 and is likely to maintain its lead throughout the forecast period. The growth of the topical segment is accounted for by increasing demand for topical products due to convenient dosage, patient compliance factors, and various strategic initiatives undertaken by market players. Topical drug dosage forms generally include suspensions, solutions, and ointments. For instance, in October 2021, Allergan an AbbVie Inc company announced that U.S. FDA has approved VUITY for the treatment of presbyopia. Vuity is the only FDA-approved eye drop to treat various eye conditions.

To Collaborate Scientific Professionals around the World

Conference Date August 28-29, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Eye & Cataract Surgery Journal of Clinical and Experimental Ophthalmology Optometry: Open Access

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by